Is TSRX a good stock to own? Find out who bought Trius Therapeutics, who sold Trius Therapeutics (TSRX) stock, and who holds a large position in Trius Therapeutics.

• Wellington Management Company owns 2.70M shares worth $18.49M
• First Eagle Investment Management owns 1.79M shares worth $12.28M
• Broadfin Capital owns 1.21M shares worth $5.79M
• Sectoral Asset Management owns 1.00M shares worth $5.85M
• Vanguard owns 997366 shares worth $6.82M
• Perceptive Advisors owns 920996 shares worth $6.59M
• Thomas Weisel Asset Management owns 782942 shares worth $3.74M
• Technical Financial Services owns 782278 shares worth $5.35M
• Redmile owns 778250 shares worth $5.32M
• Ayer Capital Management owns 509165 shares worth $2.72M
• CI Investments owns 427097 shares worth $2.46M
• AXA owns 425846 shares worth $2.91M
• STATE STREET CORPORATION owns 386101 shares worth $2.64M
• Timberline Asset Management owns 380383 shares worth $2.60M
• Callan Capital owns 318096 shares worth $2.22M
• BBT Capital Management owns 300931 shares worth $1.73M
• Manatuck Hill Partners owns 285000 shares worth $2.04M
• Shott Capital Management owns 239233 shares worth $1.28M
• Millennium Management owns 238345 shares worth $1.63M
• Alyeska Investment owns 227500 shares worth $1.31M
• Heather K. Mellem, Esq. owns 214639 shares worth $1.47M
• Balyasny Asset Management owns 213000 shares worth $1.46M
• GRT Capital Partners owns 211222 shares worth $1.44M
• Diamondback Capital Management owns 203200 shares worth $1.18M
• Dr. Jeffrey R. Jay, M.D owns 200000 shares worth $1.15M
• SMITH ASSET MANAGEMENT owns 189438 shares worth $905.51M
• Eudaimonia Asset Management owns 166613 shares worth $1.14M
• Credit Suisse AG owns 163888 shares worth $1.12M
• PanAgora Asset Management owns 161907 shares worth $773915
• TIAA-CREF Investment Management owns 153344 shares worth $1.05M
• Renaissance Technologies owns 148071 shares worth $852888
• Schroder Investment Management owns 144929 shares worth $991314
• Geode Capital Management owns 143619 shares worth $982353
• Frank Russell Company owns 141378 shares worth $948646
• Polar Capital owns 135899 shares worth $928190
• Bridgeway Capital Management owns 126700 shares worth $605626
• T. Rowe Price Associates owns 120000 shares worth $820800
• D. E. Shaw & Co owns 104279 shares worth $713268
• Ellington Management owns 92200 shares worth $630648
• Jacob Asset Management of New York owns 85000 shares worth $581400
• OrbiMed Advisors owns 81600 shares worth $437376
• NUMERIC INVESTORS owns 79288 shares worth $542329
• Two Sigma Investments owns 74971 shares worth $401844

• Bank of America Corporation sold on June 30, 2012

• Teva Pharmaceutical Industries (TEVA)
• Vertex Pharmaceuticals Incorporated (VRTX)
• Cardinal Health (CAH)
• Bristol Myers Squibb (BMY)
• WellCare Health Plans (WCG)
• McKesson Corporation (MCK)
• Allergan (AGN)
• Intuitive Surgical (ISRG)
• Gilead Sciences (GILD)
• Array BioPharma (ARRY)
• Onyx Pharmaceuticals (ONXX)
• Exelixis (EXEL)
• Salix Pharmaceuticals (SLXP)
• Celgene Corporation (CELG)
• Elan Corporation (ELN)
• Neurocrine Biosciences (NBIX)
• NuVasive (NUVA)
• Idenix Pharmaceuticals (IDIX)
• St. Jude Medical (STJ)
• HeartWare International (HTWR)
• Trius Therapeutics (TSRX)